Posted 06 February, 2023
Structure Therapeutics Inc. IPO completed
IPO completed detected for ticker Nasdaq:GPCR in a 424B4 filed on 06 February, 2023.
This is our initial public offering, and no public market currently exists for our ADSs or ordinary shares.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Structure Therapeutics Inc.
Health Care/Life Sciences • Biotechnology
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company engaged in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in San Francisco, CA.Market Cap
$1.51B
View Company Details
$1.51B
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.